151 related articles for article (PubMed ID: 34673127)
1. Circular RNA circPFKP promotes cell proliferation by activating IMPDH2 in prostate cancer.
Wang S; Chao F; Zhang C; Han D; Xu G; Chen G
Cancer Lett; 2022 Jan; 524():109-120. PubMed ID: 34673127
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer.
Zhou L; Xia D; Zhu J; Chen Y; Chen G; Mo R; Zeng Y; Dai Q; He H; Liang Y; Jiang F; Zhong W
Clin Transl Oncol; 2014 Oct; 16(10):906-13. PubMed ID: 24659377
[TBL] [Abstract][Full Text] [Related]
3. Exosome-derived circTFDP2 promotes prostate cancer progression by preventing PARP1 from caspase-3-dependent cleavage.
Ding L; Zheng Q; Lin Y; Wang R; Wang H; Luo W; Lu Z; Xie H; Ren L; Lu H; Yu C; Zhang J; Shen D; Cheng S; Xia L; Li G; Xue D
Clin Transl Med; 2023 Jan; 13(1):e1156. PubMed ID: 36597139
[TBL] [Abstract][Full Text] [Related]
4. Silencing of hepsin and inosine 5-monophosphate dehydrogenase 2 by siRNA reduces prostate cancer cells proliferation.
A Wahab N; D Dardar H; Yunus R; M Zainudin Z; M Mokhtar N
Malays J Pathol; 2022 Apr; 44(1):29-38. PubMed ID: 35484884
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis.
Shi J; Liu C; Chen C; Guo K; Tang Z; Luo Y; Chen L; Su Y; Xu K
Aging (Albany NY); 2020 Jul; 12(13):13255-13280. PubMed ID: 32645691
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA cir-ITCH Is a Potential Therapeutic Target for the Treatment of Castration-Resistant Prostate Cancer.
Li S; Yu C; Zhang Y; Liu J; Jia Y; Sun F; Zhang P; Li J; Guo L; Xiao H; Gao F; Deng X; Cai Z; Cai J
Biomed Res Int; 2020; 2020():7586521. PubMed ID: 32904490
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA Myosin Light Chain Kinase (MYLK) Promotes Prostate Cancer Progression through Modulating Mir-29a Expression.
Dai Y; Li D; Chen X; Tan X; Gu J; Chen M; Zhang X
Med Sci Monit; 2018 May; 24():3462-3471. PubMed ID: 29798970
[TBL] [Abstract][Full Text] [Related]
8. LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression.
Yao M; Shi X; Li Y; Xiao Y; Butler W; Huang Y; Du L; Wu T; Bian X; Shi G; Ye D; Fu G; Wang J; Ren S
Cell Death Dis; 2020 Aug; 11(8):638. PubMed ID: 32801300
[TBL] [Abstract][Full Text] [Related]
9. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.
Hong H; Zhu H; Zhao S; Wang K; Zhang N; Tian Y; Li Y; Wang Y; Lv X; Wei T; Liu Y; Fan S; Liu Y; Li Y; Cai A; Jin S; Qin Q; Li H
Cell Death Dis; 2019 Dec; 10(12):950. PubMed ID: 31831728
[TBL] [Abstract][Full Text] [Related]
10. Inosine monophosphate dehydrogenase 2 as a marker of aggressive and advanced prostate cancer.
Wieczorek P; Bałut-Wieczorek M; Jasinski M; Szabłoński W; Antczak A
Cent European J Urol; 2018; 71(4):399-403. PubMed ID: 30680233
[TBL] [Abstract][Full Text] [Related]
11. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.
Xing L; Yang R; Wang X; Zheng X; Yang X; Zhang L; Jiang R; Ren G; Chen J
Aging (Albany NY); 2020 Jun; 12(11):10983-11003. PubMed ID: 32497020
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.
Fellenberg J; Kunz P; Sähr H; Depeweg D
PLoS One; 2010 Aug; 5(8):e12179. PubMed ID: 20808934
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells recruited by castration-induced inflammation activation accelerate prostate cancer hormone resistance via chemokine ligand 5 secretion.
Yu Y; Zhang Q; Ma C; Yang X; Lin R; Zhang H; Liu Y; Han Z; Cheng J
Stem Cell Res Ther; 2018 Sep; 9(1):242. PubMed ID: 30257726
[TBL] [Abstract][Full Text] [Related]
14. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
15. Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy.
Wan X; Pu H; Huang W; Yang S; Zhang Y; Kong Z; Yang Z; Zhao P; Li A; Li T; Li Y
Oncotarget; 2016 Aug; 7(32):51284-51300. PubMed ID: 27323416
[TBL] [Abstract][Full Text] [Related]
16. A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer.
Capaia M; Granata I; Guarracino M; Petretto A; Inglese E; Cattrini C; Ferrari N; Boccardo F; Barboro P
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966326
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1.
Zhang X; Tao T; Liu C; Guan H; Huang Y; Xu B; Chen M
Oncol Rep; 2016 Jul; 36(1):376-82. PubMed ID: 27175617
[TBL] [Abstract][Full Text] [Related]
18. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis.
Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G
J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596
[TBL] [Abstract][Full Text] [Related]
19. ACSL4 promotes prostate cancer growth, invasion and hormonal resistance.
Wu X; Deng F; Li Y; Daniels G; Du X; Ren Q; Wang J; Wang LH; Yang Y; Zhang V; Zhang D; Ye F; Melamed J; Monaco ME; Lee P
Oncotarget; 2015 Dec; 6(42):44849-63. PubMed ID: 26636648
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circABCC4 as the ceRNA of miR-1182 facilitates prostate cancer progression by promoting FOXP4 expression.
Huang C; Deng H; Wang Y; Jiang H; Xu R; Zhu X; Huang Z; Zhao X
J Cell Mol Med; 2019 Sep; 23(9):6112-6119. PubMed ID: 31270953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
